Literature DB >> 17661041

[Fluorescence in situ hybridization. A new diagnostic dimension in cytology].

S Savic1, L Bubendorf.   

Abstract

Fluorescence in situ hybridization (FISH) is a powerful method for the identification of chromosomal aberrations to improve the diagnostic performance of cytology. FISH is applicable to almost any type of cytological specimen irrespective of cell type, staining or fixation modality. Multi-target tests for the simultaneous analysis of four chromosomes or chromosomal loci improves the sensitivity of cytological diagnosis in bladder and lung cancer and is most helpful in equivocal cytology. FISH also allows a reliable distinction between malignant mesothelioma and reactive mesothelial cells. Specific translocations can easily be detected by FISH for precise diagnosis of lymphomas and sarcomas. Testing for HER-2 amplification has become a standard method to select patients with breast cancer for therapy with trastuzumab. Co-analysis of HPV and selected genes could become a useful approach in gynecological cytology. The spectrum of diagnostic FISH applications is continuously growing.

Entities:  

Mesh:

Year:  2007        PMID: 17661041     DOI: 10.1007/s00292-007-0930-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   0.973


  30 in total

1.  A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.

Authors:  K C Halling; W King; I A Sokolova; R G Meyer; H M Burkhardt; A C Halling; J C Cheville; T J Sebo; S Ramakumar; C S Stewart; S Pankratz; D J O'Kane; S A Seelig; M M Lieber; R B Jenkins
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

2.  UroVysion multiprobe FISH in urinary cytology.

Authors:  Lukas Bubendorf; Bruno Grilli
Journal:  Methods Mol Med       Date:  2004

3.  Multitarget FISH analysis in the diagnosis of lung cancer.

Authors:  Lukas Bubendorf; Phaedra Müller; Ladina Joos; Bruno Grilli; Sandrine Vogel; Michelle Herzog; Audrey Barascud; Georg Feichter; Peter Dalquen; Michael Tamm
Journal:  Am J Clin Pathol       Date:  2005-04       Impact factor: 2.493

Review 4.  Applications of fluorescence in situ hybridization in cytopathology: a review.

Authors:  Andre M Oliveira; Christopher A French
Journal:  Acta Cytol       Date:  2005 Nov-Dec       Impact factor: 2.319

5.  Should we abandon the FISH test?

Authors:  Alan M Nieder; Mark S Soloway; Harry W Herr
Journal:  Eur Urol       Date:  2007-01-18       Impact factor: 20.096

6.  Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.

Authors:  Brian J Yoder; Marek Skacel; Ryan Hedgepeth; Denise Babineau; James C Ulchaker; Louis S Liou; Jennifer A Brainard; Charles V Biscotti; J Stephen Jones; Raymond R Tubbs
Journal:  Am J Clin Pathol       Date:  2007-02       Impact factor: 2.493

7.  Multitarget fluorescence in situ hybridization elucidates equivocal lung cytology.

Authors:  Spasenija Savic; Katharina Glatz; René Schoenegg; Peter Spieler; Georg Feichter; Michael Tamm; Lukas Bubendorf
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

8.  A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens.

Authors:  Kevin C Halling; Otis B Rickman; Benjamin R Kipp; Aaron R Harwood; Clinton H Doerr; James R Jett
Journal:  Chest       Date:  2006-09       Impact factor: 9.410

9.  Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.

Authors:  Kerstin Heselmeyer-Haddad; Viktor Janz; Philip E Castle; Nadia Chaudhri; Nicole White; Kim Wilber; Larry E Morrison; Gert Auer; Frances H Burroughs; Mark E Sherman; Thomas Ried
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 10.  Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response.

Authors:  Kurt A Jaeckle; Karla V Ballman; Ravi D Rao; Robert B Jenkins; Jan C Buckner
Journal:  J Clin Oncol       Date:  2006-03-10       Impact factor: 44.544

View more
  5 in total

Review 1.  [Pleural mesothelioma. Cytology and molecular diagnostics].

Authors:  T Vlajnic; S Savic; L Bubendorf
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry.

Authors:  Helmut P Sandeck; Oluf D Røe; Kristina Kjærheim; Helena Willén; Erik Larsson
Journal:  Diagn Pathol       Date:  2010-07-06       Impact factor: 2.644

3.  Gene amplification of EGFR and its clinical significance in various cervical (lesions) lesions using cytology and FISH.

Authors:  Qing Li; Xue Cheng; Jie Ji; Jingmin Zhang; Xiaojun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 4.  [Cytology of the urinary tract: Between uncertainty and clarity].

Authors:  L Bubendorf; P Dalquen; S Savic
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

5.  Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand.

Authors:  Xing-You Jia; Qi Yu; Zhe-Hui Zhang; Xiao-Feng Yang
Journal:  Onco Targets Ther       Date:  2012-05-07       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.